GamaMabs Pharma - AMHR2 Antibody Technology - Ownership and Business Overview

Life ScienceCompany

GamaMabs Pharma - AMHR2 Antibody Technology Ownership

Who owns GamaMabs Pharma - AMHR2 Antibody Technology?

GamaMabs Pharma - AMHR2 Antibody Technology is owned by Exelixis. It was acquired on May 4, 2021.

GamaMabs Pharma - AMHR2 Antibody Technology Business Overview

Where is GamaMabs Pharma - AMHR2 Antibody Technology headquartered?

GamaMabs Pharma - AMHR2 Antibody Technology is headquartered in Toulouse, France.

What sector is GamaMabs Pharma - AMHR2 Antibody Technology in?

GamaMabs Pharma - AMHR2 Antibody Technology is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

GamaMabs Pharma - AMHR2 Antibody Technology

Toulouse,
France,

GamaMabs Pharma's AMHR2 Antibody Technology provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GamaMabs Pharma - AMHR2 Antibody Technology

Life Science Companies , France Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for France Companies

Largest France Companies , Acquisitive France Companies , Recently Acquired France Companies , Recently Sold France Companies , Private France Companies , Public France Companies , Acquired France Companies , PE Backed France Companies
Mergr

Product

Company

Legal